Literature DB >> 23940222

Evaluation of treatment benefit: randomized controlled trials and population-based observational research.

Christopher M Booth1, Ian F Tannock.   

Abstract

Mesh：

Year:  2013        PMID： 23940222     DOI： 10.1200/JCO.2013.51.5023

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer.

Authors:  S F Hall; J C Irish; R W Gregg; P A Groome; S Rohland
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

2.  Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival.

Authors:  A G Dinmohamed; A Szabó; M van der Mark; O Visser; P Sonneveld; J J Cornelissen; M Jongen-Lavrencic; A W Rijneveld
Journal:  Leukemia       Date:  2015-08-19       Impact factor: 11.528

3.  Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma.

Authors:  Aaron S Rosenberg; Ann Brunson; Brian A Jonas; Theresa H M Keegan; Ted Wun
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

Review 4.  Challenges in translating endpoints from trials to observational cohort studies in oncology.

Authors:  Anne Gulbech Ording; Deirdre Cronin-Fenton; Vera Ehrenstein; Timothy L Lash; John Acquavella; Mikael Rørth; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2016-06-11       Impact factor: 4.790

Review 5.  Concurrent or Sequential Hormonal and Radiation Therapy in Breast Cancer: A Literature Review.

Authors:  Matthew J Cecchini; Edward Yu; Kylea Potvin; David D'souza; Michael Lock
Journal:  Cureus       Date:  2015-10-25

6.  Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.

Authors:  Stephen F Hall; Fei-Fei Liu; Brian O'Sullivan; Willa Shi; Susan Rohland; Rebecca Griffiths; Patti Groome
Journal:  Br J Cancer       Date:  2017-08-22       Impact factor: 7.640

7.  The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting.

Authors:  Stephen F Hall; Rebecca J Griffiths; Brian O'Sullivan; Fei-Fei Liu
Journal:  Head Neck       Date:  2019-02-04       Impact factor: 3.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.